Barclays PLC Vaccinex, Inc. Transaction History

Barclays PLC

  • $327 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021
SELL
$2.09 - $5.11 $1,254 - $3,066
-600 Closed
0 $0
Q4 2020

Feb 11, 2021
BUY
$1.66 - $2.35 $996 - $1,410
600 New
600 $1,000
Q3 2020

Nov 12, 2020
SELL
$1.75 - $8.19 $7 - $32
-4 Closed
0 $0
Q2 2020

Aug 12, 2020
BUY
$3.28 - $4.24 $13 - $16
4 New
4 $0

Others Institutions Holding VCNX

# of Institutions
2
Shares Held
426K
Call Options Held
0
Put Options Held
0
View Full List

About VACCINEX, INC.

VCNX Quotes by TradingView
  • Ticker VCNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,664,100
  • Market Cap $109M
  • Description
  • Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab,...
More about VCNX
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email